NTAN1 抗体
(N-terminal Asparagine Amidase (NTAN1))
The protein encoded by this gene functions in a step-wise process of protein degradation through the N-end rule pathway. This protein acts as a tertiary destabilizing enzyme that deamidates N-terminal L-Asn residues on proteins to produce N-terminal L-Asp. L-Asp substrates are subsequently conjugated to L-Arg, which is recognized by specific E3 ubiquitin ligases and targeted to the proteasome. Pseudogenes of this gene are located on the long arms of chromosomes 8, 10 and 12. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012].
recommended
recommended
recommended
NTAN1 抗体 by 适用
Find NTAN1 抗体 for a variety of species such as anti-Human NTAN1, anti-Mouse NTAN1, anti-Rat NTAN1. The species listed below are among those available. Click on a link to go to the corresponding products.
NTAN1 抗体 by 应用范围
Find NTAN1 抗体 validated for a specific application such as WB, ELISA, IHC, IF. Some of the available applications are listed below. Click on a link to go to the corresponding products.
NTAN1 抗体 by 抗体来源
Find NTAN1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
NTAN1 抗体 by 抗原表位
Find NTAN1 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.
NTAN1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal NTAN1 抗体. Click on a link to go to the corresponding products.
NTAN1 抗体 by 克隆
Find NTAN1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
NTAN1 抗体 by 标记
Find NTAN1 抗体 with a specific conjugate such as Biotin, FITC, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular NTAN1 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
ELISA, IHC, IF
Validations
- (2)
Cat. No.
ABIN7165837
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
ELISA, IHC
Validations
- (2)
Cat. No.
ABIN7246970
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN530504
Quantity
50 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN7268787
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
ELISA
Validations
Cat. No.
ABIN7165840
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA
Validations
Cat. No.
ABIN7165838
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
Cat. No.
ABIN1807449
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN2568753
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC (p)
Validations
Cat. No.
ABIN7469243
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN1918774
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN1918776
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN1918775
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN1918777
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
Cat. No.
ABIN1918778
Quantity
200 μL
Datasheet
Datasheet
Latest Publications for our NTAN1 抗体
: "Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery." in: EBioMedicine, Vol. 38, pp. 79-88, (2019) (PubMed).: "Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival." in: Scientific reports, Vol. 9, Issue 1, pp. 6535, (2019) (PubMed).
: "Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors." in: Journal for immunotherapy of cancer, Vol. 7, Issue 1, pp. 256, (2019) (PubMed).
: "Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival." in: The Journal of clinical investigation, Vol. 128, Issue 11, pp. 4770-4786, (2018) (PubMed).
: "microRNA-125a-3p is regulated by MyD88 in Legionella pneumophila infection and targets NTAN1." in: PLoS ONE, Vol. 12, Issue 4, pp. e0176204, (2017) (PubMed).
: "Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts." in: Transplant international : official journal of the European Society for Organ Transplantation, Vol. 27, Issue 9, pp. 966-76, (2014) (PubMed).
: "Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing." in: The Journal of biological chemistry, Vol. 285, Issue 52, pp. 40864-78, (2010) (PubMed).
: "Aberrant endometrial features of pregnancy in diabetic NOD mice." in: Diabetes, Vol. 56, Issue 12, pp. 2919-26, (2007) (PubMed).
: "Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase." in: The Journal of experimental medicine, Vol. 197, Issue 9, pp. 1153-63, (2003) (PubMed).
: "Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope." in: The American journal of pathology, Vol. 160, Issue 5, pp. 1669-81, (2002) (PubMed).
Aliases for NTAN1 抗体
N-terminal Asn amidase (Ntan1) 抗体N-terminal asparagine amidase (NTAN1) 抗体
PNAA 抗体
PNAD 抗体
您还需要查找其他产品吗？
- NT5M 抗体
- NT5C3L 抗体
- NT5C3 抗体
- NT5C1B 抗体
- NT5C1A 抗体
- NT5C 抗体
- NT-ProBNP 抗体
- NSUN7 抗体
- NSUN6 抗体
- NSUN5 抗体
- NSUN4 抗体
- NSUN3 抗体
- NSUN2 抗体
- NSRP1 抗体
- NSR1 抗体
- NSP5 抗体
- NSMCE4A 抗体
- NSMCE2 抗体
- NSMCE1 抗体
- NSMAF 抗体
- Nth Endonuclease III-Like 1 抗体
- NTRK3 抗体
- NTSR1 抗体
- NTSR2 抗体
- NUAK1 抗体
- NUAK2 抗体
- NUB1 抗体
- Nubbin 抗体
- NUBP2 抗体
- NUBPL 抗体
- NUCB2 抗体
- NUCB2 抗体
- Nuclear Antigen 抗体
- Nuclear Casein Kinase and Cyclin-Dependent Kinase Substrate 1 抗体
- Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha 抗体
- Nuclear Receptor Subfamily 1, Group D, Member 2 抗体
- Nuclear Receptor Subfamily 1, Group H, Member 2/3 抗体
- Nuclear Receptor Subfamily 2, Group C, Member 1 抗体
- Nuclear Transcription Factor Y, beta 抗体
- Nucleobindin 1 抗体
You are here:
